News Release: GFH Acquires Big Sky Asset Management
The acquisition further enhances GFH’s US presence Builds on its thematic focus on attractive and defensive markets Manama, 03 January 2023 – GFH Financial Group (“GFH” of the “Group”) today announced it has completed the acquisition of a majority stake in Big Sky Asset Management (“Big Sky”), a US-based real estate asset manager focused on […]
Feature Story: HRE developers see plenty of opportunities in 2023
Headwinds are likely to slow activity, but the need for projects will remain strong By John B. Mugford With so many economic headwinds facing almost all business sectors, even the recession-resistant healthcare real estate (HRE) sector, why is a group of development professionals involved in the HRE space remaining so optimistic? Both medical office building […]
News Release: Remedy Medical Properties and Kayne Anderson Real Estate acquire $131 million, 13-property portfolio
FOR IMMEDIATE RELEASE Acquisition of the 300,328-square-foot Project Prism (Montecito) Portfolio consisting of 13 fully leased medical office properties in eight states closed in late December CHICAGO and BOCA RATON, Fla., Jan. 4, 2023 – Joint venture (JV) partners Remedy Medical Properties and Kayne Anderson Real Estate announced today that they have acquired the Project […]
News Release: UC Investments Creates Strategic Venture with Blackstone to Invest $4 Billion in BREIT Common Shares
Oakland, CA, and New York, January 3, 2023 – The Office of the Chief Investment Officer of the Regents of the University of California (“UC Investments”) and Blackstone (NYSE: BX) today announced a long-term strategic venture in which UC Investments will invest $4 billion in Blackstone Real Estate Income Trust, Inc. (“BREIT”) Class I common […]
News Release: Bristol Myers Squibb Completes Sale of Manufacturing Facility in Syracuse, New York
January 03, 2023 06:59 AM Eastern Standard Time NEW YORK–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) has completed the previously announced sale of its manufacturing facility in Syracuse, New York to LOTTE BIOLOGICS. The divestiture is part of Bristol Myers Squibb’s ongoing evolution of its manufacturing network to support its product portfolio. As part of the […]
